Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
12-CDA, 2-chloro-2'-deoxy-ß-D-adenosine1件: Cladribine (2-chloro-2′-deoxy-adenosine)1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
22-CDA, 2-chloro-2?-deoxy-ß-D-adenosine1件: Cladribine (2-chloro-2′-deoxy-adenosine)1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
32-CDA, 2-chloro-2’-deoxy-ß-D-adenosine1件: Cladribine (2-chloro-2′-deoxy-adenosine)1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
42-chloro-2?-deoxy-ß-D-adenosine----1件: 13 💬
52-chloro-2’-deoxy-ß-D-adenosine----1件: 13 💬
6Adenosine1件: Adenosine (Adenosine)1件: Adenosine (Adenosine) 💬 4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬 		13件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 13, 58, 65 💬